MA
48
-2
HCA
30
2
DFS
64
4
AKAM
37
-2
SHW
33
2
VFC
50
-4
AMP
43
3
C
51
5
RF
47
4
BBY
50
-2
KMX
42
-12
SIG
41
-2
ADI
54
5
AAP
36
-8
VRSK
42
4
PEG
60
3
LYB
34
16
UA
53
3
HIG
46
2
QRVO
25
17
MA
48
-2
HCA
30
2
DFS
64
4
AKAM
37
-2
SHW
33
2
VFC
50
-4
AMP
43
3
C
51
5
RF
47
4
BBY
50
-2
KMX
42
-12
SIG
41
-2
ADI
54
5
AAP
36
-8
VRSK
42
4
PEG
60
3
LYB
34
16
UA
53
3
HIG
46
2
QRVO
25
17
Financhill
Back

First Trust Europe AlphaDEX Fund Vs. Aligos Therapeutics Industry Stock Comparison

Sell
22

FEP
First Trust Europe AlphaDEX Fund

Last Price:
$35.83
Seasonality Move:
2.1%
Buy
69

ALGS
Aligos Therapeutics

Last Price:
$43.44
Seasonality Move:
-17.17%
Sell
22
First Trust Europe AlphaDEX Fund (FEP) is a Sell

Is First Trust Europe AlphaDEX Fund a Buy, Sell or Hold?

  • The current First Trust Europe AlphaDEX Fund [FEP] share price is $35.79. The Score for FEP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • FEP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
69
Aligos Therapeutics (ALGS) is a Buy

Is Aligos Therapeutics a Buy, Sell or Hold?

  • The current Aligos Therapeutics [ALGS] share price is $43.42. The Score for ALGS is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
  • ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FEP Stock Price Chart

What is First Trust Europe AlphaDEX Fund's stock price today?

  • The First Trust Europe AlphaDEX Fund share price today is $35.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FEP is experiencing slight selling pressure.

ALGS Stock Price Chart

What is Aligos Therapeutics's stock price today?

  • The Aligos Therapeutics share price today is $43.42
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing buying pressure, which is a positive indicator for future bullish movement.

FEP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 39.32 Sell
Chaikin Money Flow: -4077 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (35.82 - 37.2) Sell
Bollinger Bands (100): (36.6 - 38.56) Sell

ALGS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.14 Buy
Relative Strength Index (14 RSI): 74.33 Buy
Chaikin Money Flow: 210748 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (27.82 - 40.1) Buy
Bollinger Bands (100): (6.77 - 28.07) Buy

FEP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.84 Sell
20-day SMA: 36.46 Sell
50-day SMA: 36.86 Sell
200-day SMA: 37.72 Sell
8-day EMA: 35.89 Sell
20-day EMA: 36.23 Sell
50-day EMA: 36.78 Sell
200-day EMA: 37.14 Sell

ALGS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.78 Buy
20-day SMA: 36.11 Buy
50-day SMA: 23.97 Buy
200-day SMA: 16.97 Buy
8-day EMA: 40.32 Buy
20-day EMA: 35.95 Buy
50-day EMA: 27.43 Buy
200-day EMA: 19.22 Buy

First Trust Europe AlphaDEX Fund Earnings Growth & FEP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Aligos Therapeutics Earnings Growth & ALGS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.65 per share, and a decrease next year of $0.14 per share.

First Trust Europe AlphaDEX Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aligos Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):